Handelsbanken Fonder AB - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.45 and the average weighting 0.0%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$70
-99.9%
79,200
+14.6%
0.00%
-100.0%
Q3 2022$108,000
-22.3%
69,1000.0%0.00%0.0%
Q2 2022$139,000
-13.7%
69,1000.0%0.00%0.0%
Q1 2022$161,000
-49.8%
69,1000.0%0.00%
-50.0%
Q4 2021$321,000
-31.4%
69,100
+12.7%
0.00%0.0%
Q3 2021$468,000
-21.2%
61,3000.0%0.00%
-33.3%
Q2 2021$594,000
+61.4%
61,300
+37.8%
0.00%
+50.0%
Q1 2021$368,000
+21.1%
44,5000.0%0.00%0.0%
Q4 2020$304,00044,5000.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 15,001$1,4100.00%
KLCM Advisors, Inc. 20,000$1,8800.00%
AlphaMark Advisors, LLC 3,135$00.00%
TRUST CO OF VERMONT 204$190.00%
SlateStone Wealth, LLC 30,866$30.00%
Coppell Advisory Solutions LLC 100$890.00%
Highlander Capital Management, LLC 1,200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Russell Investments Group, Ltd. 266$250.00%
OGOREK ANTHONY JOSEPH /NY/ /ADV 3,600$00.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders